Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the documentation or interface. It does not reflect changes to the study information or results.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNew help/navigation sections have been added to the study record page, including How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment header formatting was updated and the revision label changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating a minor platform update. No study information appears to have changed.SummaryDifference0.1%

- Check50 days agoChange DetectedA new Revision: v3.5.4 appears, replacing the previous Revision: v3.5.3. This indicates a backend or documentation update to the page rather than changes to study data or content.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.5.3 replaces the previous v3.5.2, indicating a new release of the ClinicalTrials.gov platform.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.